引用本文: | 陈永升,黄琴,尹晓林.自体造血干细胞移植对急性髓系白血病的治疗进展[J].中国临床新医学,0,():-. |
| Yongsheng chen,Qin huang,Xiaolin yin.自体造血干细胞移植对急性髓系白血病的治疗进展[J].中国临床新医学,0,():-. |
|
摘要: |
自20世纪80年代至今,自体造血干细胞移植已成为一种治疗急性髓系白血病(AML)的主要疗法。目前自体造血干细胞移植成为因难以找到人类白细胞抗原(HLA)配型相合者而不能行异基因造血干细胞移植的主要治疗手段。本文综述了自体造血干细胞移植在低危、中高危AML及难治性或复发性AML患者中的治疗进展,且追踪了降低自体造血干细胞移植治疗AML复发率的策略。 |
关键词: 自体造血干细胞 移植 急性髓系白血病 人类白细胞抗原 |
DOI: |
分类号: |
基金项目:广西卫生厅自筹基金课题(课题编号:Z2014357) |
|
Therapy progress of autologous hematopoietic stem cells transplantation on |
Yongsheng chen, Qin huang, Xiaolin yin
|
Department of Hematology,303rd Hospital of the People`s Liberation Army,Plant Road 52,Nanning,Guangxi,China,530021
|
Abstract: |
Since 1980s, autologous hematopoietic stem cells transplantation(auto-HSCT) was developed as one of the main therapies for hundreds of thousands patients with acute myeloid leukemia(AML),who can not find HLA-matched related donor and do allogeneic hematopoietic stem cell transplantation.have been cured since in. This article aims at reviewing the progress of auto-HSCT in treating the low risk,intermedia risk, high risk. and refractory or recurrent of AML,and review strategy about decreasing the relapse of auto-HSCT therapy . |
Key words: autologoushematopoietic stem cell transplantation acute myeloid leukemia human leucocyte antigen |